Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Mustang Bio, Inc.

NASDAQ: MBIOHealthcare / Biotechnology / -
4.09-0.1100-2.62%Vol 62 6211Y Perf -62.43%
Feb 20th, 2019 16:00
BID4.08 ASK4.11
Open4.29 Previous Close4.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
18.00 
Analyst Rating
Strong Buy 1.00
Potencial %
340.10 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)112 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
19.47 
Earnings Date
4th Apr 2019

Today's Price Range

4.014.30

 

52wk Range

2.1811.99

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
23.56%
3 Months
-3.76%
6 Months
-36.79%
1 Year
-62.43%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
MBIO4.09-0.1100-2.62
AAPL172.031.10000.64
GOOG1 113.80-4.7600-0.43
MSFT107.15-1.0200-0.94
XOM78.530.30000.38
WFC49.810.43000.87
JNJ136.350.66000.49
FB162.560.27000.17
GE10.10-0.0300-0.30
JPM105.690.51000.48
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
10.10
Current Ratio
10.30
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-38 646.00
EBITDA Margin
-38 006.00
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.82
PS Ratios
2 350.12
Price to Cash Flow
-
Price to Free Cash Flow
-6.20
Cash Flow Per Share
-0.67
Price to Tangible Book
2.82
Book Value per Share
1.65
Enterprise Value (in ths.)
86 215
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-62.67
Return on Assets (5Y Avg)
-
ROA last 12 Months
-58.76
Return on Capital (5Y Avg)
-
ROC last 12 Months
-63.70
Return on invested Capital Q
-15.85
Return on invested Capital Y
-75.58
Assets Turnover
0.00
Receivables Turnover
0.40
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
50
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.20-0.28-40.00
Q02 2018-0.25-0.1924.00
Q01 2018-0.23-0.24-4.35
Q04 2017-0.24-0.228.33
----
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.270.00-
12/2018 FY-0.980.00-
3/2019 QR-0.270.00-
12/2019 FY-1.150.00-
Next Report Date4th Apr 2019
Estimated EPS Next Report-0.27
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume62 621
Shares Outstanding (in ths.)27 263
Trades Count225
Dollar Volume212 786
Avg. Volume64 729
Avg. Weekly Volume61 859
Avg. Monthly Volume81 605
Avg. Quarterly Volume80 292

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

59%41%

Bearish Bullish

55%45%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News